glp-1 receptor agonist diarrhea management Frontiers Ozempic (Semaglutide): GLP-1 receptor agonist

This excludes a subgroup with lesser degrees of weight loss, but which is still clinically relevant

Despite their established benefits, these medications are often underprescribed, particularly in primary care settings where concerns about cost, complexity of use, and potential side effects persist

Posaconazole shields against invasive fungal infections

Liraglutide is another GLP-1 receptor agonist, most commonly used either as mono- or combined therapy

Established applications demonstrate robust efficacy in diabetes management (HbA1c reductions of 1.52.0%), obesity treatment (weight loss of 724%), and cardiovascular protection (1420% reduction in major adverse cardiovascular events, or MACE)